CRYSTAL EDWARDS: Open Payments
NPI 1992795041 · BLADENBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$754 in 32 payments from 12 companies in 2025. Trend: 2023 $222 · 2024 $50 · 2025 $754
Food & beverage: $673Education: $81
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $269 |
| REVANCE THERAPEUTICS, INC. | 2 | $123 |
| Regeneron Healthcare Solutions, Inc. | 3 | $112 |
| Lilly USA, LLC | 4 | $74 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $31 |
| UCB, Inc. | 1 | $27 |
| Incyte Corporation | 1 | $26 |
| Organon LLC | 2 | $23 |
| Verrica Pharmaceuticals Inc. | 1 | $22 |
| Arcutis Biotherapeutics, Inc. | 1 | $16 |
Products named: SKYRIZI, DAXXIFY, DUPIXENT, TALTZ, RINVOQ, ILUMYA, Bimzelx, OPZELURA.
Industry payments across NC — which companies pay providers there.
